Covaxin safe for booster dose against Covid: Bharat Biotech

Booster BBV152 vaccination is safe and may be necessary to ensure persistent immunity to prevent breakthrough infections. Bharat Biotech on Saturday said trials have indicated that its vaccine Covaxin is safe for booster dosage against COVID-19. The analysis showed, six months after a two-dose Covaxin (BBV152) vaccination series cell-mediated immunity and neutralising antibodies to both … Read more

Covid vaccination for children: What are the govt guidelines and how to register

The Centre has also set guidelines for this vaccination drive and the SOP outlines types of vaccine that can be administered and the method of reserving slots. India is getting ready to start administering Covid-19 vaccines to children aged between 15 and 18 years from January 3, 2022, after Prime Minister Narendra Modi’s announcement on … Read more

Booster doses on the way! Here’s why India gears up for this ‘precautionary dose’

PM Modi in a surprise address to the nation on December 25 announced that cpvod-19 vaccination for children in the 15-18 age group will start from January 3. The World Health Organisation has stated that the booster doses of covid vaccines should be introduced based on firm evidence, for those groups who are at higher … Read more

For now, Covaxin likely to be only Covid vaccine available for children of 15-18 yrs

The decisions came amid rising Covid cases linked to the Omicron variant of the virus. Bharat Biotech’s Covaxin is likely to be the only COVID-19 vaccine available, for now, for children in the age group of 15-18 years, who will be inoculated from January 3, official sources said. Also, healthcare and frontline workers and citizens … Read more

Bharat Biotech seeks nod for Phase-3 trials of nasal Covid-19 vaccine

Bharat Biotech’s nasal vaccine, BBV154, has already completed Phase-2 trials with Covaxin. The proposed Ph-3 trials will cover those who have been administered with any two doses of the Covid-19 vaccine. Vaccine maker Bharat Biotech has sought regulatory nod to conduct Phase-3 trials of its nasal Covid-19 vaccine that can be used as a booster … Read more

Bharat Biotech seeks nod for phase-3 trials of intranasal COVID-19 vaccine as booster dose

An intranasal vaccine as a booster dose would be easier to administer in mass vaccination campaigns and has the potential to prevent transmission. Bharat Biotech has sought the Drug Controller General of India’s approval to conduct phase-3 trials of its COVID-19 intranasal vaccine (BBV154) to use as booster dose, sources said on Monday. “The application … Read more

Bharat Biotech donates 200,000 doses of Covaxin to Vietnam

Covaxin and help boost Vietnam’s national vaccination programme. Bharat Biotech and its local partner Dunc Minh have donated 200,000 doses of Covaxin to the Republic of Vietnam. The Covid-19 vaccine has received emergency use listing in Vietnam. Suchitra Ella, joint managing director of Bharat Biotech, said the donation was a gesture of goodwill to provide … Read more

Bharat Biotech, Dunc Minh donate 2 lakh Covaxin doses to Vietnam

The donation represents a gesture of goodwill to provide access to Bharat Biotech’s Covaxin to fight COVID- 19 pandemic across borders. The Republic of Vietnam will receive 2,00,000 doses of Bharat Biotech’s COVID-19 vaccine, a top official of the company said on Thursday. The announcement was made by Suchitra Ella, Joint Managing Director of Bharat … Read more

Covid-19: Why technical advisory panel wants booster dose to be different than first two vaccines

If and when the recommendation for a booster is made, beneficiaries vaccinated with Covishield, Sputnik V, and are likely to have multiple options. (File) A Covid-19 booster dose, when administered, should be of a vaccine based on a different platform than the first two doses, according to preliminary consensus reached by India’s top technical advisory … Read more

Bharat Biotech begins Covaxin exports, says on track to make 1 bn doses a year

On efficacy against the Omicron variant, Bharat Biotech said Covaxin was developed against the original Wuhan variant and has worked against other variants, and the company would continue to research on new variants. Vaccine maker Bharat Biotech on Monday said it has commenced exports of its Covid-19 vaccine Covaxin. The company said the first set … Read more